ReviewExploration of targeted anti-tumor therapy2026

More than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer.

Luis Molina Calistro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.